Forte Capital’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.63M Sell
4,026
-46
-1% -$19.2K 0.18% 95
2025
Q1
$2.03M Buy
4,072
+572
+16% +$310K 0.24% 80
2024
Q4
$1.82M Sell
3,500
-364
-9% -$200K 0.2% 83
2024
Q3
$2.39M Sell
3,864
-157
-4% -$92.9K 0.27% 72
2024
Q2
$2.22M Sell
4,021
-113
-3% -$64.7K 0.27% 68
2024
Q1
$2.4M Sell
4,134
-83
-2% -$46.6K 0.3% 64
2023
Q4
$2.24M Sell
4,217
-371
-8% -$180K 0.31% 63
2023
Q3
$2.32M Sell
4,588
-10
-0.2% -$5.33K 0.36% 57
2023
Q2
$2.4M Sell
4,598
-88
-2% -$47.5K 0.35% 59
2023
Q1
$2.7M Hold
4,686
0.41% 53
2022
Q4
$2.58M Sell
4,686
-218
-4% -$116K 0.44% 50
2022
Q3
$2.49M Buy
4,904
+54
+1% +$30.2K 0.45% 51
2022
Q2
$2.63M Sell
4,850
-458
-9% -$252K 0.46% 52
2022
Q1
$3.54M Hold
5,308
0.45% 45
2021
Q4
$3.54M Buy
5,308
+1,900
+56% +$1.19M 0.45% 45
2021
Q3
$1.95M Sell
3,408
-75
-2% -$41.2K 0.26% 60
2021
Q2
$1.76M Sell
3,483
-165
-5% -$77.9K 0.24% 69
2021
Q1
$1.67M Sell
3,648
-25
-0.7% -$11.9K 0.26% 62
2020
Q4
$1.71M Sell
3,673
-471
-11% -$221K 0.26% 60
2020
Q3
$1.83M Sell
4,144
-94
-2% -$38.8K 0.34% 52
2020
Q2
$1.54M Buy
+4,238
New +$1.42M 0.32% 56
2018
Q1
Sell
-7,183
Closed -$1.36M 155
2017
Q4
$1.36M Sell
7,183
-600
-8% -$115K 0.41% 61
2017
Q3
$1.47M Sell
7,783
-170
-2% -$30.8K 0.47% 52
2017
Q2
$1.39M Sell
7,953
-100
-1% -$16.8K 0.46% 55
2017
Q1
$1.24M Sell
8,053
-1,065
-12% -$163K 0.42% 60
2016
Q4
$1.29M Sell
9,118
-300
-3% -$44.2K 0.48% 57
2016
Q3
$1.5M Sell
9,418
-400
-4% -$61.6K 0.57% 49
2016
Q2
$1.45M Sell
9,818
-650
-6% -$95.9K 0.56% 49
2016
Q1
$1.48M Sell
10,468
-375
-3% -$50.3K 0.65% 46
2015
Q4
$1.54M Sell
10,843
-300
-3% -$40K 0.63% 45
2015
Q3
$1.36M Sell
11,143
-213
-2% -$27.8K 0.62% 45
2015
Q2
$1.47M Sell
11,356
-159
-1% -$20.7K 0.63% 43
2015
Q1
$1.56M Sell
11,515
-295
-2% -$38K 0.67% 41
2014
Q4
$1.48M Sell
11,810
-525
-4% -$63.8K 0.64% 44
2014
Q3
$1.5M Buy
+12,335
New +$1.5M 0.69% 44

Other funds holding TMO